Prnewswire·2026-02-12 19:35Core Insights - Guardant Health has launched a Community Colorectal Cancer Screening Grant Program to enhance access to colorectal cancer screening during March, which is Colorectal Cancer Awareness Month [1] - The program will provide selected organizations with up to 100 Shield tests at no cost to support community health fairs, screening events, and educational outreach [1] - Shield is the first FDA-approved blood test for colorectal cancer screening for adults aged 45 and older at average risk, offering a more convenient option compared to traditional methods [1] Company Initiatives - The grant program aims to remove barriers to screening, particularly in underserved communities, and supports organizations that focus on health outreach [1] - Applications for the grant are open until February 17, 2026, with notifications of approval sent on February 20, 2026 [1] - Organizations interested in applying are encouraged to review the Request for Proposals and complete the application form [1] Product Information - Shield is a non-invasive blood-based screening test that detects alterations associated with colorectal cancer, intended for individuals aged 45 and older at average risk [1] - A positive result from the Shield test indicates the need for further evaluation through colonoscopy [1] - Guardant Health is focused on transforming patient care and accelerating cancer therapies through advanced testing and analytics [1]